The U.S. Food and Drug Administration today announced another major step in its initiative to streamline the development of biosimilar medicines, which are like “generic” versions of biologic drugs.
FDA News Releases published a clinical update in Research Highlights on 09 Mar 2026. The item focuses on FDA Takes Further Steps to Streamline Biosimilar Development and Make Medicines More Affordable. Open the detail page to review the full original feed content.